Improving myocardial perfusion by percutaneous coronary intervention reduces central sympathetic activity in stable angina

Clin Cardiol. 2010 Jun;33(6):E16-21. doi: 10.1002/clc.20676.

Abstract

Background: By stimulating sympathetic afferents, repetitive myocardial ischemia induces a state of increased sympathetic tone.

Hypothesis: Removing the ischemic trigger by revascularization using percutaneous coronary intervention (PCI) might thus reduce central sympathetic activity in symptomatically stable angina patients.

Methods: A total of 20 patients with stable angina > or = New York Heart Association (NYHA) class II with persistent symptoms despite maximal pharmacological therapy and a clinical indication for PCI, were included in our study. Sympathetic nervous system activity was measured before and 1 month after PCI by a combination of techniques: direct muscle sympathetic nerve activity (MSNA), neurochemical (plasma catecholamine levels), and heart rate variability (HRV).

Results: All patients completed the study. After PCI there was a significant reduction in MSNA (pre-PCI 72 +/- 4 to post-PCI 53 +/- 4 burst/100 beats, P < .05) and low frequency/high frequency (LF/HF) ratio (3.7 +/- 0.6 vs 2.4 +/- 0.4, P < .05) consistent with a decline in sympathetic activity. Plasma norepinephrine levels were reduced after PCI, but this difference did not reach statistical significance (1.84 +/- 0.17 vs 1.73 +/- 0.13 nmol/L, P = not significant).

Conclusion: Coronary revascularization by PCI reduces sympathetic activity in patients with established myocardial ischemia.

MeSH terms

  • Aged
  • Angina Pectoris / blood
  • Angina Pectoris / etiology
  • Angina Pectoris / physiopathology
  • Angina Pectoris / therapy*
  • Angioplasty, Balloon, Coronary*
  • Biomarkers / blood
  • Coronary Circulation*
  • Electric Stimulation
  • Electrocardiography
  • Female
  • Heart Rate
  • Humans
  • Male
  • Middle Aged
  • Muscle, Skeletal / innervation
  • Myocardial Ischemia / blood
  • Myocardial Ischemia / complications
  • Myocardial Ischemia / physiopathology
  • Myocardial Ischemia / therapy*
  • Netherlands
  • Norepinephrine / blood
  • Severity of Illness Index
  • Sympathetic Nervous System / metabolism
  • Sympathetic Nervous System / physiopathology*
  • Time Factors
  • Treatment Outcome

Substances

  • Biomarkers
  • Norepinephrine